Cystic Acne Treatment Guidelines

First-Line Treatment

For moderate-to-severe cystic acne, the American Academy of Dermatology recommends initiating doxycycline 100 mg daily combined with a topical retinoid and benzoyl peroxide as first-line therapy 1, 2
Oral doxycycline should be dosed at 100 mg daily (or 100 mg twice daily on day 1, then 100 mg daily) 3
Topical retinoid, such as adapalene 0.3% gel, tretinoin 0.1% cream/gel, or tazarotene 0.1% gel, should be applied nightly 1
Benzoyl peroxide, 2.5-5% gel, should be applied in the morning (or as fixed combination with retinoid) 1
The duration of oral antibiotics should be limited to 3-4 months maximum to prevent bacterial resistance 2, 3

For severe or scarring cystic acne, the Journal of the American Academy of Dermatology recommends isotretinoin 0.5-1 mg/kg/day for 15-20 weeks as the definitive treatment 4
Isotretinoin dosing should be 0.5-1 mg/kg/day for 15-20 weeks 4
Baseline monitoring should include liver function tests and lipid panel 4
Ongoing monitoring should include repeat liver function tests and lipid panel at least once during treatment 4

For individual large, painful cystic lesions, the Journal of the American Academy of Dermatology recommends injecting triamcinolone acetonide 10 mg/mL (diluted to 5 or 3.3 mg/mL) to flatten nodules within 48-72 hours 4
Intralesional corticosteroids should be used with caution, as they can cause local atrophy, pigmentary changes, and telangiectasias if overdosed 4

After achieving clearance with oral antibiotics or isotretinoin, the American Academy of Dermatology recommends continuing topical retinoid monotherapy indefinitely to prevent recurrence 1
Preferred agents for maintenance therapy include adapalene 0.1-0.3% gel or tretinoin 0.025-0.1% cream/gel 1

Extending oral antibiotics beyond 3-4 months increases antibiotic resistance risk 2, 3
Using topical or oral antibiotics without benzoyl peroxide rapidly induces bacterial resistance 1, 2
Underestimating severity when scarring is present indicates need for aggressive treatment (isotretinoin) regardless of lesion count 1
Failing to counsel about photosensitivity, as doxycycline-induced photosensitivity is common and severe 2, 3